Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice
- 21 July 2009
- journal article
- Published by Springer Science and Business Media LLC in Neurotoxicity Research
- Vol. 17 (2), 142-155
- https://doi.org/10.1007/s12640-009-9091-4
Abstract
Parkinson's disease (PD) is characterized by a triade of motor symptoms due to the degeneration of nigrostriatal pathway. In addition to these motor impairments, cognitive disturbances have been reported to occur in PD patients in the early stage of the disease. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin widely used to produce experimental models of PD. In a previous work, we showed that MPTP altered the expression of proteins involved in mTOR antiapoptotic and PKR apoptotic pathways of translational control (TC) in neuroblastoma cells. In the present study, the results indicated that a subchronic MPTP intoxication in mice decreased the dopaminergic neuron number, produced an activation of PKR way and an inhibition of mTOR way of TC especially in striatum and frontal cortex associated with a great activation of PKR in hippocampus. Moreover, in parallel to biochemical analysis, the mnesic disturbances induced by MPTP were characterized in C57Bl/6 mice, by testing their performance in three versions of the Morris Water Maze task. Behavioral results showed that the MPTP lesion altered mice learning of a spatial working memory, of a cued version and of a spatial reference memory task in the water maze. Furthermore, we previously demonstrated that the neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP) could counteract the MPTP toxicity on TC factors in neuroblastoma cells. Thus, the second objective of our study was to assess the PACAP effect on MPTP-induced TC impairment and cognitive deficit in mice. The pretreatment with PACAP27 by intravenous injections partially protected TH-positive neuron loss induced by MPTP, prevented the MPTP-induced protein synthesis control dysregulation and mnesic impairment of mice. Therefore, our results could indicate that PACAP may be a promising therapeutic agent in Parkinson's disease.Keywords
This publication has 76 references indexed in Scilit:
- PACAP stimulates the sustained phosphorylation of tyrosine hydroxylase at serine 40Cellular Signalling, 2007
- eIF2α Phosphorylation Bidirectionally Regulates the Switch from Short- to Long-Term Synaptic Plasticity and MemoryCell, 2007
- Protective Effects of PACAP in Excitotoxic Striatal LesionAnnals of the New York Academy of Sciences, 2006
- Translational control of hippocampal synaptic plasticity and memory by the eIF2α kinase GCN2Nature, 2005
- PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenoneFEBS Letters, 2005
- mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's diseaseJournal of Neurochemistry, 2005
- Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTPCell and tissue research, 2004
- Ribosomal S6 Kinase Signaling and the Control of TranslationExperimental Cell Research, 1999
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal of Neural Transmission, 1996
- Recent physiological and pathophysiological aspects of Parkinsonian movement disordersLife Sciences, 1984